A subgroup analysis from the IMvigor130 study in patients with upper tract vs. lower tract locally advanced or metastatic urothelial carcinoma treated with atezolizumab plus platinum-based chemotherapy
Title:
A subgroup analysis from the IMvigor130 study in patients with upper tract vs. lower tract locally advanced or metastatic urothelial carcinoma treated with atezolizumab plus platinum-based chemotherapy
Author:
Bamias, A. De Santis, M. Grande, E. Marina, M. Li, J-R. Puente, J. Izumi, K. Lee, J.L. Kose, F. Antonyan, I. Ding, B. Patel, H. Davis, I.